The following are the most recent pieces of Forex technical analysis from around the world. The Forex technical analysis below covers the various currencies on the market and the most recent trends, technical indicators, as well as resistance and support levels.
USD/BRL continues to consolidate near 5.3571 within a well-defined range, with traders watching for potential breakout catalysts from the upcoming U.S. Federal Reserve interest rate decision.
The USD/ZAR has reaffirmed its bearish trend the past handful of days and is lingering within the lower realms of its value once again, as of this morning the currency pair is near 17.11850 with fast action.
USD/CAD remains rangebound, stalling at 1.40 resistance and the 50-day EMA, with the pair consolidating between 1.39 and 1.41 amid cross-border trade noise and dollar volatility.
Bitcoin plunged more than 6% on Monday, testing the crucial $80,000 level as fears of institutional exit raise the risk of a deeper selloff toward $75,000 or even $55,000.
EUR/JPY dipped early Monday but continues to hold above key support as the weak yen supports a broader uptrend, unless the 175 level breaks decisively.
The British pound stalled near key moving averages on Monday as traders remain cautious ahead of central bank decisions, with GBP/USD biased lower unless 1.3350 is broken.
The euro’s rally against the US dollar stalled near 1.1650 on Monday, as market uncertainty ahead of the Fed's decision keeps EUR/USD trading choppy with a slight bearish bias.
Current developments and energy policy in the US have caused a renewed interest in oil stocks. A fundamental disconnect due to bearish sentiment in oil stocks and depressed oil prices has created an attractive valuation, stable dividends, and notably more upside potential than downside risk. Learn about the best oil stocks to buy today.
The Global Electric Vehicle Market report expects the EV market to grow 26.8% annually and exceed 34.8 million units by 2030. Find out about the best EV stocks to buy today!
Biotech stocks offer exciting investment opportunities, but they carry greater risk than traditional pharmaceutical stocks. Learn about the best biotech stocks to buy now!
Two promising developments, expanding profit margins and increased earnings-per-share guidance for 2025, drive a bullish narrative. Can the post-earnings rally in Labcorp continue?
A massive 30%+ correction overshadows AI adoption, strong operational metrics, and a healthy dividend yield. Did the sell-off create a buy signal in Paychex?
One spin-off complete, two more to come in 2026, with high earnings-per-share expectations, and 25%+ upside potential. Time to go long oh Honeywell?
It is significant that key support levels continue to hold firm.
Silver extended its explosive rally toward $60 on Monday as short covering and physical demand fueled gains, but extreme volatility makes chasing the move highly risky.
